Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs)

Hamm CW, Schneck E, Buerke M, Darius H, Gaede L, Bergmann M, Hoffmeister M, Schneck F, Gräsner JT, Dirkmann D, Sander M (2021)


Publication Type: Journal article, Review article

Publication year: 2021

Journal

DOI: 10.1007/s12181-020-00439-4

Abstract

The anticoagulation strategy in patients suffering from an acute coronary syndrome prior to hospital admission plays a pivotal role in the treatment. Patients treated with non-vitamin K antagonist oral anticoagulants (NOACs) are at a higher risk for bleeding complications but currently no specific recommendations for the prehospital anticoagulation management of these patients exists. This joint consensus paper summarizes the current knowledge and makes recommendations for the treatment of this particular patient group. In summary, patients suffering from an acute coronary syndrome with ST-elevation should receive acetylsalicylic acid and heparin independently of the last intake of non-vitamin K antagonist oral anticoagulants. Furthermore, acetylsalicylic acid is indicated in patients presenting with angina pectoris and lack of ST-elevation while heparin should only be administered after careful individual consideration of the risks and benefits.

Involved external institutions

How to cite

APA:

Hamm, C.W., Schneck, E., Buerke, M., Darius, H., Gaede, L., Bergmann, M.,... Sander, M. (2021). Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs). Der Kardiologe. https://doi.org/10.1007/s12181-020-00439-4

MLA:

Hamm, Christian W., et al. "Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs)." Der Kardiologe (2021).

BibTeX: Download